[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Achieve Life Sciences Inc (ACHV)

Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 481,471
  • Shares Outstanding, K 102,659
  • Annual Sales, $ 0 K
  • Annual Income, $ -54,650 K
  • EBIT $ -52 M
  • EBITDA $ -52 M
  • 60-Month Beta 2.25
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 22.94

Options Overview Details

View History
  • Implied Volatility 96.49% (-8.01%)
  • Historical Volatility 124.57%
  • IV Percentile 6%
  • IV Rank 2.35%
  • IV High 656.67% on 03/02/26
  • IV Low 82.99% on 07/02/25
  • Expected Move (DTE 25) 0.99 (21.02%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 574
  • Volume Avg (30-Day) 924
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 35,721
  • Open Int (30-Day) 34,115
  • Expected Range 3.70 to 5.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.20
  • Number of Estimates 2
  • High Estimate $-0.18
  • Low Estimate $-0.21
  • Prior Year $-0.37
  • Growth Rate Est. (year over year) +45.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.93 +19.34%
on 04/27/26
6.15 -23.74%
on 05/12/26
+0.46 (+10.87%)
since 04/22/26
3-Month
2.62 +79.01%
on 03/30/26
6.15 -23.74%
on 05/12/26
+0.42 (+9.84%)
since 02/20/26
52-Week
2.00 +134.50%
on 06/27/25
6.15 -23.74%
on 05/12/26
+1.72 (+57.91%)
since 05/22/25

Most Recent Stories

More News
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment

ORCA-OL data complete the clinical evidence package supporting the cytisinicline smoking cessation NDA No new safety signals identified by the independent Data Safety Monitoring Committee over 52...

ACHV : 4.69 (+1.96%)
Achieve Life Sciences Q1 Earnings Call Highlights

Achieve Life Sciences (NASDAQ:ACHV) used its first-quarter 2026 earnings call to outline a transition period marked by new leadership, a major financing, manufacturing changes tied to its cytisinicline...

ACHV : 4.69 (+1.96%)
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma

SEATTLE and VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on...

ACHV : 4.69 (+1.96%)
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates

Closed Private Placement of Up to $354 Million, Including $180 Million Upfront and $174 Million in Milestone-Driven Warrants Appoints New CEO and Expands Board of Directors Advances U . S...

ACHV : 4.69 (+1.96%)
Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

SEATTLE and VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and...

ACHV : 4.69 (+1.96%)
Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors

Achieve Names Two New Exemplary Healthcare Leaders to its Board of Directors  New Leadership and Financing, up to $354 Million ($180 Million Upfront and $174 Million Dependent on the Exercise of...

ACHV : 4.69 (+1.96%)
Achieve Life Sciences Announces Up to $354 Million Private Placement

$180 Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations,...

ACHV : 4.69 (+1.96%)
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions

Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing Capability Company Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027...

ACHV : 4.69 (+1.96%)
Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

SEATTLE and VANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development...

ACHV : 4.69 (+1.96%)
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Achieve also Announces Partnership with U.S.-based   Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call Scheduled for 8:30 AM EDT Today, March 24, 2026 SEATTLE and VANCOUVER,...

ACHV : 4.69 (+1.96%)

Business Summary

Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc.,...

See More

Key Turning Points

3rd Resistance Point 4.98
2nd Resistance Point 4.90
1st Resistance Point 4.79
Last Price 4.69
1st Support Level 4.60
2nd Support Level 4.52
3rd Support Level 4.41

See More

52-Week High 6.15
Last Price 4.69
Fibonacci 61.8% 4.56
Fibonacci 50% 4.07
Fibonacci 38.2% 3.59
52-Week Low 2.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.